Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel

To see complete record on, please visit this link

Id: NCT05046184

Organisation Name: University of Texas Southwestern Medical Center

Overal Status: Recruiting

Start Date: May 5, 2022

Last Update: May 26, 2022

Lead Sponsor: University of Texas Southwestern Medical Center

Brief Summary: The study is investigating dysfunctions in neurocircuitry in regards to irritability with healthy controls (HC) and individuals with Major Depressive Disorder (MDD) by performing MRIs. The MDD group will also be randomized to receive ketamine or midazolam to investigate changes post-treatment in neurocircuitry with regards to irritability.

  • Major Depressive Disorder
  • Healthy Controls

Total execution time in seconds: 0.39523100852966